Xiang Y, Sun G, Tian L, Xiang P, Xie C
Ann Hematol. 2025; .
PMID: 39918600
DOI: 10.1007/s00277-025-06241-0.
Xie A, Wang H, Zhao J, Wang Z, Xu J, Xu Y
Brief Bioinform. 2024; 26(1).
PMID: 39681325
PMC: 11649301.
DOI: 10.1093/bib/bbae655.
Ospina O, Manjarres-Betancur R, Gonzalez-Calderon G, Soupir A, Smalley I, Tsai K
Cancer Res. 2024; 85(5):848-858.
PMID: 39636739
PMC: 11873723.
DOI: 10.1158/0008-5472.CAN-24-2346.
Ianevski A, Nader K, Driva K, Senkowski W, Bulanova D, Moyano-Galceran L
Nat Commun. 2024; 15(1):8579.
PMID: 39362905
PMC: 11450203.
DOI: 10.1038/s41467-024-52980-5.
Liu C, Zhang Y, Liang Y, Zhang T, Wang G
Brief Bioinform. 2024; 25(6).
PMID: 39350337
PMC: 11442150.
DOI: 10.1093/bib/bbae490.
PIPET: predicting relevant subpopulations in single-cell data using phenotypic information from bulk data.
Ruan X, Cheng Y, Ye Y, Wang Y, Chen X, Yang Y
Brief Bioinform. 2024; 25(4).
PMID: 38819254
PMC: 11141296.
DOI: 10.1093/bib/bbae260.
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.
Johnson T, Sudha P, Liu E, Becker N, Robertson S, Blaney P
Nat Commun. 2024; 15(1):4144.
PMID: 38755140
PMC: 11099140.
DOI: 10.1038/s41467-024-48327-9.
scRank infers drug-responsive cell types from untreated scRNA-seq data using a target-perturbed gene regulatory network.
Li C, Shao X, Zhang S, Wang Y, Jin K, Yang P
Cell Rep Med. 2024; 5(6):101568.
PMID: 38754419
PMC: 11228399.
DOI: 10.1016/j.xcrm.2024.101568.
Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value.
Du J, Gu X, Yu X, Cao Y, Hou J
Blood Sci. 2023; 5(4):221-236.
PMID: 37941914
PMC: 10629747.
DOI: 10.1097/BS9.0000000000000172.
CellSTAR: a comprehensive resource for single-cell transcriptomic annotation.
Zhang Y, Sun H, Zhang W, Fu T, Huang S, Mou M
Nucleic Acids Res. 2023; 52(D1):D859-D870.
PMID: 37855686
PMC: 10767908.
DOI: 10.1093/nar/gkad874.
Deep Learning Techniques with Genomic Data in Cancer Prognosis: A Comprehensive Review of the 2021-2023 Literature.
Lee M
Biology (Basel). 2023; 12(7).
PMID: 37508326
PMC: 10376033.
DOI: 10.3390/biology12070893.
Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI.
Liu C, Zhang Y, Gao X, Wang G
BMC Biol. 2023; 21(1):159.
PMID: 37468850
PMC: 10354926.
DOI: 10.1186/s12915-023-01658-3.
scAB detects multiresolution cell states with clinical significance by integrating single-cell genomics and bulk sequencing data.
Zhang Q, Jin S, Zou X
Nucleic Acids Res. 2022; 50(21):12112-12130.
PMID: 36440766
PMC: 9757078.
DOI: 10.1093/nar/gkac1109.
Spatial Transcriptomic Analysis Reveals Associations between Genes and Cellular Topology in Breast and Prostate Cancers.
Alsaleh L, Li C, Couetil J, Ye Z, Huang K, Zhang J
Cancers (Basel). 2022; 14(19).
PMID: 36230778
PMC: 9562681.
DOI: 10.3390/cancers14194856.
Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction.
Gandhi M, Bakhai V, Trivedi J, Mishra A, de Andres F, LLerena A
Transl Oncol. 2022; 25:101532.
PMID: 36103755
PMC: 9478452.
DOI: 10.1016/j.tranon.2022.101532.
Bioinformatics roadmap for therapy selection in cancer genomics.
Jimenez-Santos M, Garcia-Martin S, Fustero-Torre C, Di Domenico T, Gomez-Lopez G, Al-Shahrour F
Mol Oncol. 2022; 16(21):3881-3908.
PMID: 35811332
PMC: 9627786.
DOI: 10.1002/1878-0261.13286.
Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to disease.
Johnson T, Yu C, Huang Z, Xu S, Wang T, Dong C
Genome Med. 2022; 14(1):11.
PMID: 35105355
PMC: 8808996.
DOI: 10.1186/s13073-022-01012-2.
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.
Ghamlouch H, Boyle E, Blaney P, Wang Y, Choi J, Williams L
J Exp Clin Cancer Res. 2021; 40(1):380.
PMID: 34857028
PMC: 8638425.
DOI: 10.1186/s13046-021-02185-1.